“Comparison of Safety and Economic Burden of Dipeptidyl Peptidase-4-Inhibitor Versus Sulfonylureas in Type 2 Diabetes Patients Inadequately Controlled With Metformin; A Narrative Review”. 2020. Indian Journal of Public Health Research & Development 11 (7): 1063-69. https://doi.org/10.37506/ijphrd.v11i7.10232.